Actelion to Pay $360 Million in DoJ Settlement

21.12.2018 - In a settlement with the US Justice Department (DoJ) Actelion Pharmaceuticals, a Johnson & Johnson subsidiary, has agreed to pay $360 million to settle civil claims it used a...